These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 27643472)
1. Cardioprotective effects of intracoronary administration of 4-chlorodiazepam in small and large animal models of ischemia-reperfusion. Tsamatsoulis M; Kapelios CJ; Katsaros L; Vakrou S; Sousonis V; Sventzouri S; Michelinakis N; Perrea DN; Anastasiou-Nana M; Malliaras K Int J Cardiol; 2016 Dec; 224():90-95. PubMed ID: 27643472 [TBL] [Abstract][Full Text] [Related]
2. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration. Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671 [TBL] [Abstract][Full Text] [Related]
3. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion. Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289 [TBL] [Abstract][Full Text] [Related]
4. Intracoronary Infusion of Thioflavin-S to Study Microvascular Obstruction in a Model of Myocardial Infarction. Hervas A; de Dios E; Forteza MJ; Miñana G; Nuñez J; Ruiz-Sauri A; Bonanad C; Perez-Sole N; Chorro FJ; Bodi V Rev Esp Cardiol (Engl Ed); 2015 Nov; 68(11):928-34. PubMed ID: 26253860 [TBL] [Abstract][Full Text] [Related]
5. Evaluation cardioprotective effects of atorvastatin in rats by real time myocardial contrast echocardiography. Filusch A; Buss S; Hardt S; Katus HA; Kuecherer HF; Hansen A Echocardiography; 2008 Oct; 25(9):974-81. PubMed ID: 18771549 [TBL] [Abstract][Full Text] [Related]
6. Intracoronary Administration of Allogeneic Cardiosphere-Derived Cells Immediately Prior to Reperfusion in Pigs With Acute Myocardial Infarction Reduces Infarct Size and Attenuates Adverse Cardiac Remodeling. Sousonis V; Sfakianaki T; Ntalianis A; Nanas I; Kontogiannis C; Aravantinos D; Kapelios C; Katsaros L; Nana M; Sampaziotis D; Sanoudou D; Papalois A; Malliaras K J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):88-99. PubMed ID: 32677460 [TBL] [Abstract][Full Text] [Related]
7. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction. Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066 [TBL] [Abstract][Full Text] [Related]
8. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model. Dai W; Amoedo ND; Perry J; Le Grand B; Boucard A; Carreno J; Zhao L; Brown DA; Rossignol R; Kloner RA Cardiovasc Drugs Ther; 2022 Apr; 36(2):217-227. PubMed ID: 33555510 [TBL] [Abstract][Full Text] [Related]
9. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model. Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665 [TBL] [Abstract][Full Text] [Related]
10. Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs. Koudstaal S; Oerlemans MI; Van der Spoel TI; Janssen AW; Hoefer IE; Doevendans PA; Sluijter JP; Chamuleau SA Eur J Clin Invest; 2015 Feb; 45(2):150-9. PubMed ID: 25496079 [TBL] [Abstract][Full Text] [Related]
11. Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. Kanazawa H; Tseliou E; Malliaras K; Yee K; Dawkins JF; De Couto G; Smith RR; Kreke M; Seinfeld J; Middleton RC; Gallet R; Cheng K; Luthringer D; Valle I; Chowdhury S; Fukuda K; Makkar RR; Marbán L; Marbán E Circ Heart Fail; 2015 Mar; 8(2):322-32. PubMed ID: 25587096 [TBL] [Abstract][Full Text] [Related]
12. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial. Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442 [TBL] [Abstract][Full Text] [Related]
13. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction. Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747 [TBL] [Abstract][Full Text] [Related]
14. [Beneficial effects of fosinopril on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion]. Zhao JL; Yang YJ; Jing ZC; Wu YJ; You SJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):638-42. PubMed ID: 16080815 [TBL] [Abstract][Full Text] [Related]
15. Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery. García-Ruiz JM; Galán-Arriola C; Fernández-Jiménez R; Aguero J; Sánchez-González J; García-Alvarez A; Nuno-Ayala M; Dubé GP; Zafirelis Z; López-Martín GJ; Bernal JA; Lara-Pezzi E; Fuster V; Ibáñez B Basic Res Cardiol; 2017 Mar; 112(2):17. PubMed ID: 28188434 [TBL] [Abstract][Full Text] [Related]
16. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion]. Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):679-83. PubMed ID: 15932731 [TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of the novel selective endothelin-A receptor antagonist BSF 461314 in ischemia-reperfusion injury. Hansen A; Bekeredjian R; Filusch A; Wolf D; Gross ML; Mueller S; Korosoglou G; Kuecherer HF J Am Soc Echocardiogr; 2005 Nov; 18(11):1213-20. PubMed ID: 16275532 [TBL] [Abstract][Full Text] [Related]
18. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model. Dai W; Hale S; Kloner RA Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128 [TBL] [Abstract][Full Text] [Related]
19. Reduction of no-reflow and reperfusion injury with the synthetic 17β-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade. Hernández-Reséndiz S; Palma-Flores C; De Los Santos S; Román-Anguiano NG; Flores M; de la Peña A; Flores PL; Fernández-G JM; Coral-Vázquez RM; Zazueta C Basic Res Cardiol; 2015 Mar; 110(2):1. PubMed ID: 25589055 [TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model. Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]